Hanson McClain Advisors »

Eyepoint Pharmaceuticals shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Eyepoint Pharmaceuticals (EYPT) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Eyepoint Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eyepoint Pharmaceuticals held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eyepoint Pharmaceuticals by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $11k 593 18.27
2025-09-30 $1.3k 93 14.25
2025-06-30 $876 93 9.42

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Series Trust State Street Spd (SPYG)
Spdr Series Trust State Street Spd (SPYV)
Ishares Tr Us Treas Bd Etf (GOVT)
Apple Call Call Option (Principal) (AAPL)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Gmo Etf Trust Gmo Us Quality E (QLTY)
Ishares Tr Mbs Etf (MBB)
Ishares Tr Usd Inv Grde Etf (USIG)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Hanson McClain Advisors

Top funds holding Eyepoint Pharmaceuticals

Cormorant Asset Management
Suvretta Capital Management
BlackRock
Federated Investors
Adage Capital Partners GP
Franklin Resources
Vanguard Group
Paradigm Biocapital Advisors
TCG Crossover Management
OrbiMed Advisors
Citadel Advisors
Geode Capital Management
State Street Corporation
Standard Life Aberdeen
Goldman Sachs Group

View all funds holding Eyepoint Pharmaceuticals